Vivani Medical
VANI
43 hedge funds and large institutions have $8.8M invested in Vivani Medical in 2017 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
0.02% less ownership
Funds ownership: 0.58% → 0.56% (-0.02%)
2% less funds holding
Funds holding: 44 → 43 (-1)
7% less capital invested
Capital invested by funds: $9.48M → $8.8M (-$680K)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $6K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$108K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$74.7K |
| 3 |
Squarepoint
New York
|
+$48.7K |
| 4 |
FTI
Fiduciary Trust International
Lincoln,
Massachusetts
|
+$30.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$29.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Element Capital Management
New York
|
-$142K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$117K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$90K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$63K |
| 5 |
Millennium Management
New York
|
-$58K |
VANI Hedge Fund Activity: Q3 2017 in Review
43 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q3 2017, worth a combined $8.8M — down 7.2% from $9.48M a quarter earlier.
Fund positioning in VANI was balanced in Q3 2017: 9 funds opened new positions, 9 closed out, 5 added to existing stakes and 10 trimmed.
The largest buyer was UBS Group, adding an estimated $108K. The largest seller was Element Capital Management, exiting entirely with an estimated $142K sold.
- 43 institutional investors held Vivani Medical (VANI) as of Q3 2017, down from 44 in Q2 2017.
- Funds reported $8.8M of Vivani Medical stock for Q3 2017, down 7.2% quarter-over-quarter.
- 9 funds opened new Vivani Medical positions in Q3 2017 and 9 closed out, a net change of 0 holders.
- The largest Vivani Medical buyer in Q3 2017 was UBS Group, an estimated $108K added.
- The largest Vivani Medical seller in Q3 2017 was Element Capital Management, an estimated $142K sold.
Based on aggregated 13F filings for Q3 2017.